DAFTAR KEPUSTAKAAN
Akbar HN (2007). Hepatitis B dan Hepatitis C. Dalam : Sulaiman A. Akbar HN. Lesmana LA. Noer MS. Ed: Buku Ajar Penyakit Hati. Edisi 1. Jakarta: FK.UI; 201-8
Amirudin R (2007). Fibrosis Hati. Dalam : Sulaiman A. Akbar HN. Lesmana LA. Noer MS. Buku Ajar Ilmu Penyakit Hati 1. Jakarta: Penerbit Jayabadi : 329-33
Arthur LM, Laurent C et al (2008). Validation and Comparison of Simple Non Invasive Indexes for Predicting Liver Fibrosis in HIV-HCV Coinfected Patients. The American Journal of Gastroenterology;103(8):1973-80
Al-Ghamdi AS (2010). FibroScan: A Noninvasive Test of Liver Fibrosis
Assessment. [online] Available at:
Amellal N, Raissouni F, Achour J, et al (2009). Correlation study between liver biopsy and transient elastometry (FIBROSCAN) for the assessment of fibrosis during viral hepatitis C. Arab journal of Gastroenterology. 10: AB10-AB17
Bataller R. Brenner DA (2005). Liver Fibrosis Dalam The Journal of Clinical Investigation. 115 : 209-16
Brunt EM (2000). Grading and Staging the Histopatological Lesions of Chronic Hepatitis : The Knodell Histology Activity Index and Beyond. Hepatology : 241-6
Franciscus A. (2010). HCV Diagnostic Tools: Grading and Staging a Liver
Biopsy. [online] Available at:
Friedman SL (2003). Liver Fibrosis-From Bench to Bedside. J. Hepatol. 38: S38-S53
Fung JY, Lai CL, Yuen MF (2009). Clinical Application of Transient Elastography (Fibroscan) in Liver Diseases. The Hongkong Medical Diary;14(11):22-4
Galeras JA, Jimeno M, Tural C et al (2008). Confirmation of the accuracy of FIB-4, a simple marker of fibrosis in HCV patients with and without HIV Co-Infection. Universitat Autonoma de Barcelona, Hospital Del Mar, Barcelona, Spain
Grigorescu M (2010). Noninvasive Biochemical Markers of Liver Fibrosis. University of Medicine and Pharmacy. [online] Available at:
Gressner AM. Weiskirchen R (2006). Modern Pathogenic Concepts of Liver Fibrosis Suggest Stellate Cells and TGF - α as Major Players and Therapeutic Targets. Journal of Cellular and Molecular Medicine.10: 76-99
Hasan Irsan (2009). Patofisiologi dan Gambaran klinis Fibrosis Hati. Pertemuan Ilmiah Tahunan, Ilmu Penyakit Dalam. Jakarta.FK-UI;171-78
Hui AY, Chan HLY, Wong VWS, et al (2005). Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive models. Am J Gastroenterol; 616-23
Kwang GL, Yeon SS, Hyonggin A, et al (2010). Usefullness of Non-invasive Markers for Predicting Liver Cirrhosis in Patients with Chronic Hepatitis B. Journal of Gastroenterology and Hepatology, 25(1): 94-100
Kajihara M, Kato S, Okazak Y, et al (2003). A role of Autoantibody-Mediated Platelet Destruction in Thrombocytopenia in Patients with cirrhosis. Hepatology. 37: 1267-76
Kun Z, Chun FG, Yun PZ, et al (2010). Simpler Score of Routine Laboratory Tests Predicts Liver Fibrosis in Patients with Chronic Hepatitis B. Journal of Gastroenterology and Hepatology. 96(4): 1569-77
Kim SU, Han KH, Ahn SA (2010). Transient elastography in chronic hepatitis B: An asian perspective. World J Gastroenterol; 16(41): 5173-5180
Kyung KB, Young KD, Yong PJ et al (2010). Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus infected patients. Liver International;30(4):546-53
Ledinghen VD, Vergniol J (2008). Transient elastography (FibroScan). Gastroenterol Clin Bio. 32: 58-67
Mallet V, Vernier VD, Roussins C et al (2009). The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Alimentary Pharmacology & Therapeutics;29:409-15
Mahassadi AK, Attia AK, Bathaix FM (2010). Diagnostic accuracy of biochemical markers of fibrosis in black African patients with chronic hepatitis B. Health;2(12):1413-20
Marcellin (2009). Non-invasive assessment of liver fibrosis by measurement of stiffness in patient with chronic hepatitis B. Liver Internationale, 29(2): 242-247
Nalpas B, Mallet V, Pichard V et al (2009). The FIB-4 index is accurate to assess liver fibrosis before and during treatment in chronic hepatitis B. Poster Presentation;Apr 23, 2009
Pichard AV, Mallet V, Nalpas B et al (2007). FIB-4: an Inexpensive and Accurate Marker of Fibrosis in HCV Infection. Comparison with Liver Biopsy and FibroTest. Hepatology;46:32-6
Pinzani M, Rombouts K, Colagrande S (2005). Fibrosis in Chronic Liver Disease: Diagnosis and Management. Journal of Hepatology. 42: 22-36
Poynard T, Morra R, Ingiliz P, et al (2008). Assesment of Liver Fibrosis : Noninvasive Means : 14:163-173
Sembiring J (2009). “Korelasi kadar thrombopoietin serum dengan fibrosis hati pada penderita hepatitis kronik.” Diss; 1-16
Soemohardjo S, Gunawan S (2009). Hepatitis B Kronik. Dalam: A.W. Sudoyo, B. Setiyohadi, I. Alwi, M. Simadibrata, S. Setiati, eds., 2009. Buku Ajar Ilmu Penyakit Dalam. Jakarta: Penerbit InternaPublishing: 653-57
Sirli R, Sporea I, et al (2010). A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection. Hepatitis Monthly; 10(2): 88-94
Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004; 351:438-50
Tsukada S, Parsons CJ, Rippe RA (2006). Mechanism of Liver fibrosis. Clinica Chimica Acta; 364: 33-60
Tural C, Jou A et al (2008). Combination of Transient Elastometry and Simple Biochemic Tests as First Line Assessment of Liver Fibrosis in HIV/HCV Coinfected Patients in Routine Clinical Practice. Clin Gastroenterol Hepatol(in press)
Wolber EM, Jelkmann W (2002). Thrombopoietin : The Novel Hepatic Hormone. News Physiol Sci. 17: 6-10
Wai CT, Cheng CL, Wee A, et al (2006). Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver International: 26: 666-72
Wu SD, Wang JY et al (2010). Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative study. World Journal of Gastroenterology;16(4):501-7
Ziol M, Handra-Luca A, Kettaneh A, et al (2005). Noninvasive assessment of liver fibrosis by measurement of stiffness in patient with chronic hepatitis C. Hepatology, 41(1); 48-54
